ɪn ˈeɪpɹəl tˈuː θˈaʊzənd nˈaɪn, dʒˈɛnəntˌɛk ˈɪŋk. ɐnˈaʊnst ɐ fˈeɪzd vˈɑːləntɚɹi wɪθdɹˈɔːl ʌv ɹˈæptɪvə fɹʌmðə jˈuː.ˈɛs. mˈɑːɹkɪt.
In April 2009, Genentech Inc. announced a phased voluntary withdrawal of Raptiva from the U.S. market.